<?xml version="1.0" encoding="UTF-8"?>
<ref id="pmed.1002422.ref056">
 <label>56</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Anderson</surname>
   <given-names>PL</given-names>
  </name>, 
  <name>
   <surname>Reirden</surname>
   <given-names>D</given-names>
  </name>, 
  <name>
   <surname>Castillo-Mancilla</surname>
   <given-names>J</given-names>
  </name>. 
  <article-title>Pharmacologic considerations for preexposure prophylaxis in transgender women</article-title>. 
  <source>J Acquir Immune Defic Syndr</source>. 
  <year>2016</year>;
  <volume>72</volume>(
  <issue>Suppl 3</issue>):
  <fpage>S230</fpage>â€“
  <lpage>4</lpage>. 
  <comment>doi: 
   <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/qai.0000000000001105" xmlns:xlink="http://www.w3.org/1999/xlink">10.1097/qai.0000000000001105</ext-link>
  </comment>
  <?supplied-pmid 27429188?>
  <pub-id pub-id-type="pmid">27429188</pub-id>
 </mixed-citation>
</ref>
